Pathological and radiological features of false-positive lesions on [68Ga]Ga-PSMA-11 PET/CT in primary staging of prostate cancer: a radio-pathology matching analysis

被引:0
|
作者
Li, Renjie [1 ,2 ]
Fu, Yao [3 ]
Peng, Shan [3 ]
Yang, Fengjiao [4 ]
Ai, Shuyue [4 ]
Wang, Feng [4 ]
Zhang, Shun [1 ,2 ]
Guo, Hongqian [1 ,2 ]
Qiu, Xuefeng [1 ,2 ]
机构
[1] Nanjing Univ, Med Sch, Nanjing Drum Tower Hosp, Dept Urol,Affiliated Hosp, Nanjing 210008, Peoples R China
[2] Nanjing Univ, Inst Urol, Nanjing 210008, Peoples R China
[3] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Dept Pathol,Med Sch, Nanjing 210008, Peoples R China
[4] Nanjing Med Univ, Nanjing Hosp 1, Dept Nucl Med, Nanjing 210029, Peoples R China
基金
中国国家自然科学基金;
关键词
Ga-68]Ga-PSMA-11 PET/CT; Pathological feature; False-positive; True-negative; True-positive; MULTIPARAMETRIC MRI; EMISSION-TOMOGRAPHY; GA-68-PSMA PET/CT; PI-RADS; DIAGNOSIS; ACCURACY;
D O I
10.1007/s00259-025-07148-8
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose The aim of this study was to investigate the radiological and pathological characteristics of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT during the primary staging of prostate cancer. Methods This study retrospectively analyzed 216 prostate cancer patients who had [Ga-68]Ga-PSMA-11 PET/CT before radical prostatectomy. False-positive lesion was defined as suspicious lesion with PRIMARY score >= 3 on PET/CT but benign on whole-mount pathology. To analyze the radiological and pathological features of false-positive lesions, no-uptake areas on PSMA PET/CT with benign pathology on the whole-mount specimen were randomly delineated and defined as true-negative lesions. The pathological features of false-positive and true-negative lesions were compared using Fisher's exact test. The differences of SUVmax and SUVmean between false-positive and true-positive lesions were determined and compared using the Wilcoxon matched-pairs signed-ranks test. In addition, PSMA expression in false-positive lesions was assessed by immunohistochemistry. Results A total of 36 false-positive lesions were identified on [Ga-68]Ga-PSMA-11 PET/CT: 25 (69.44%) were simple atrophy with cyst formation, 7 (19.44%) were prostatic nodular hyperplasia, 3 (8.33%) were inflammation and 1 (2.78%) was normal glands. A comparable number of 36 true-negative lesions were delineated: 21 (58.33%) were normal glands, 8 (22.22%) were simple atrophy with cyst formation, 6 (16.67%) were prostatic nodular hyperplasia, and 1 (2.78%) were inflammation. The Fisher's exact test revealed a statistically significant difference in the prevalence of simple atrophy with cyst formation between false-positive and true-negative lesions (69.44% vs. 22.22%; P < 0.001). Differences in SUVmax and SUVmean between false-positive and true-positive lesions were also statistically significant (both P < 0.001). PSMA expression in false-positive lesions was confirmed via immunohistochemistry. Conclusion This study determined that simple atrophy with cyst formation is a distinctive pathological feature of false-positive lesions on [Ga-68]Ga-PSMA-11 PET/CT. This observation is likely attributable to the elevated PSMA expression in simple atrophy with cyst formation, as confirmed by histological analysis. Additionally, false-positive lesions were found to have significantly lower SUV compared to true-positive lesions.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Systemic Therapy Response Evaluation in Prostate Carcinoma with [68Ga]Ga-PSMA-11 PET/CT
    Kucuker, K.
    Yapar, Z.
    Guney, I.
    Paydas, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S502 - S503
  • [22] Retrospective analysis of thyroid incidentalomas detected by [68Ga]Ga-PSMA-11 PET/CT
    Kocar, Ilkcan Cerci
    Ozcan, Pinar Pelin
    Koc, Zehra Pinar
    Sule, Mehmet
    Akbay, Esen
    Gen, Ramazan
    Sezer, Kerem
    ENDOCRINE, 2024, 86 (01) : 302 - 309
  • [23] A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
    Guochang Wang
    Linlin Li
    Ming Zhu
    Jie Zang
    Jiarou Wang
    Rongxi Wang
    Weigang Yan
    Lin Zhu
    Hank F. Kung
    Zhaohui Zhu
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 3126 - 3136
  • [24] A prospective head-to-head comparison of -[68Ga]Ga-P16-093 and -[68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
    Wang, Guochang
    Li, Linlin
    Zhu, Ming
    Zang, Jie
    Wang, Jiarou
    Wang, Rongxi
    Yan, Weigang
    Zhu, Lin
    Kung, Hank F.
    Zhu, Zhaohui
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (10) : 3126 - 3136
  • [25] A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer
    Wang, Guochang
    Li, Linlin
    Zang, Jie
    Wang, Jiarou
    Zhu, Lin
    Kung, Hank F.
    Zhu, Zhaohui
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [26] Clinical utility of [68Ga]Ga-PSMA-11 PET/CT in initial staging of patients with prostate cancer and importance of intraprostatic SUVmax values
    Rogic, Ivan
    Golubic, Anja Tea
    Zuvic, Marijan
    Smitran, Tea
    Jukic, Nino
    Gamulin, Marija
    Kastelan, Zeljko
    Huic, Drazen
    NUCLEAR MEDICINE REVIEW, 2024, 27 : 6 - 12
  • [27] Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based radiomics Signature for Primary Prostate Cancer Characterization
    Ghezzo, S.
    Bharathi, P. Gurunath
    Duan, H.
    Mapelli, P.
    Davidzon, G.
    Bezzi, C.
    Chung, B.
    Gajate, A. Samanes
    Thong, A.
    Russo, T.
    Brembilla, G.
    Loening, A.
    Ghanouni, P.
    Briganti, A.
    De Cobelli, F.
    Sonn, G.
    Chiti, A.
    Iagaru, A.
    Moradi, F.
    Picchio, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S231 - S231
  • [28] The influence of digital PET/CT on diagnostic certainty and interrater reliability in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer
    Ian Alberts
    Jan-Niklas Hünermund
    Christos Sachpekidis
    Clemens Mingels
    Viktor Fech
    Karl Peter Bohn
    Axel Rominger
    Ali Afshar-Oromieh
    European Radiology, 2021, 31 : 8030 - 8039
  • [29] The influence of digital PET/CT on diagnostic certainty and interrater reliability in [68Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer
    Alberts, Ian
    Huenermund, Jan-Niklas
    Sachpekidis, Christos
    Mingels, Clemens
    Fech, Viktor
    Bohn, Karl Peter
    Rominger, Axel
    Afshar-Oromieh, Ali
    EUROPEAN RADIOLOGY, 2021, 31 (10) : 8030 - 8039
  • [30] Prostate Cancer Biochemical Recurrence Resulted Negative on [68Ga]Ga-PSMA-11 but Positive on [18F]Fluoromethylcholine PET/CT
    Laudicella, Riccardo
    La Torre, Flavia
    Davi, Valerio
    Croce, Ludovica
    Arico, Demetrio
    Leonardi, Giuseppe
    Russo, Simona
    Minutoli, Fabio
    Burger, Irene A.
    Baldari, Sergio
    TOMOGRAPHY, 2022, 8 (05) : 2471 - 2474